Liver Diseases & Advanced Liver Treatment in Agra: From Fatty Liver to Cirrhosis, Hepatitis and Liver Cancer

Modern Diagnosis, FibroScan, Advanced Medicines, Endoscopy, TIPS, Liver Cancer Therapy & Liver Transplantation Explained

By Dr. Karan R. Rawat
MBBS, MS, FIAGES, FMAS, DMAS, FICRS, FALS, FISCP, FAIAS, MCLS, FCLS
Gastrointestinal, Liver, Pancreas, Gastro Surgery, Laparoscopic & General Surgery, Agra

Medically reviewed: September 2026

The liver is one of the most important organs in the human body—and unfortunately, significant liver disease can sometimes develop without producing obvious symptoms in its early stages.

A person may feel completely normal despite having:

  • Fatty liver

  • Liver fibrosis

  • Chronic hepatitis B

  • Chronic hepatitis C

  • Early cirrhosis

  • Portal hypertension

The good news is that liver medicine has changed considerably.

Today, many liver diseases can be detected earlier using blood-based fibrosis assessment, FibroScan or elastography, modern imaging and targeted laboratory tests. Hepatitis C can usually be cured with modern oral medicines; hepatitis B can often be effectively suppressed; selected patients with metabolic liver disease now have disease-specific drug options; complications of portal hypertension can be treated using endoscopic and radiological techniques; and selected patients with advanced liver failure or liver cancer may benefit from transplantation.

For patients in Agra, Mathura, Firozabad, Tundla, Shikohabad, Hathras, Etah, Mainpuri, Bharatpur, Dholpur, Vrindavan and surrounding areas, understanding the stage and cause of liver disease is far more important than simply being told:

“Your liver enzymes are increased.”

What Does the Liver Actually Do?

The liver performs hundreds of important functions.

It helps:

  • Process nutrients

  • Store energy

  • Produce bile

  • Produce proteins needed for blood clotting

  • Regulate cholesterol

  • Process medicines

  • Remove or modify toxins

  • Support immunity

  • Maintain multiple metabolic functions

This is why severe liver disease can eventually affect not only digestion but also the brain, kidneys, blood circulation, nutrition and immune system.

What Are the Common Liver Conditions?

Some of the most important liver diseases seen in clinical practice include:

1. Fatty Liver / MASLD

Previously commonly called NAFLD, fatty liver associated with metabolic problems is now increasingly termed:

MASLD — Metabolic Dysfunction-Associated Steatotic Liver Disease

It is closely associated with:

  • Obesity

  • Abdominal obesity

  • Diabetes

  • Prediabetes

  • High triglycerides

  • High cholesterol

  • High blood pressure

  • Metabolic syndrome

Some patients progress from simple fat accumulation to inflammation and fibrosis.

The inflammatory progressive form is called:

MASH — Metabolic Dysfunction-Associated Steatohepatitis.

2. Alcohol-Associated Liver Disease

Regular harmful alcohol intake can lead progressively to:

Fat accumulation → inflammation → fibrosis → cirrhosis → liver failure

The most important treatment is complete alcohol abstinence once significant alcohol-related liver disease has developed.

In advanced disease, stopping alcohol can be one of the most important interventions for survival.

3. Hepatitis B

Hepatitis B is a viral infection that may become chronic.

Chronic hepatitis B can eventually produce:

  • Fibrosis

  • Cirrhosis

  • Liver failure

  • Liver cancer

Not every HBsAg-positive patient automatically requires antiviral treatment.

Evaluation may include:

  • HBsAg

  • HBeAg

  • Anti-HBe

  • HBV DNA viral load

  • Liver enzymes

  • Fibrosis assessment

  • Ultrasound

  • Other tests according to the patient's condition

For people who meet treatment criteria, modern high-resistance-barrier antiviral medicines such as tenofovir or entecavir are recommended first-line options internationally. These medicines suppress viral replication and reduce the risk of progressive liver damage, although they should not usually be described as a routine “cure” for chronic hepatitis B.

4. Hepatitis C

Hepatitis C treatment represents one of the greatest advances in modern liver medicine.

Older interferon-based treatment was prolonged and could cause substantial side effects.

Today, direct-acting antiviral medicines—DAAs—can cure more than 95% of hepatitis C infections in appropriately treated patients.

Treatment is usually oral and often relatively short.

But an important point remains:

Curing the virus does not automatically erase advanced cirrhosis that already developed before treatment.

Patients with significant fibrosis or cirrhosis may still require long-term liver monitoring after HCV cure.

5. Liver Fibrosis

Fibrosis means scarring of the liver.

It may develop because of:

  • Fatty liver/MASH

  • Alcohol

  • Hepatitis B

  • Hepatitis C

  • Autoimmune liver disease

  • Certain metabolic disorders

  • Cholestatic liver disease

Fibrosis can progress through increasing stages before reaching cirrhosis.

Detecting fibrosis before cirrhosis develops is one of the major objectives of modern liver care.

6. Cirrhosis

Cirrhosis means advanced scarring that changes the normal structure and function of the liver.

A patient can initially have:

Compensated cirrhosis

The liver remains able to perform many essential functions.

Later the patient may develop:

Decompensated cirrhosis

Complications may include:

  • Ascites

  • Variceal bleeding

  • Hepatic encephalopathy

  • Jaundice

  • Kidney dysfunction

  • Recurrent infections

  • Liver failure

Cirrhosis itself generally cannot simply be “washed out” or cured with a liver tonic. Treating its underlying cause can prevent or slow progression, and complications can often be actively managed.

7. Portal Hypertension

Scarred liver tissue can obstruct normal blood flow through the liver.

This raises pressure in the portal venous system.

This condition is called:

Portal Hypertension

It may lead to:

  • Enlarged spleen

  • Low platelet count

  • Esophageal varices

  • Gastric varices

  • Ascites

  • Collateral veins

  • Variceal bleeding

Modern management ranges from medicines and endoscopic treatment to advanced radiological procedures such as TIPS in appropriately selected patients.

8. Ascites

Ascites means abnormal accumulation of fluid inside the abdomen.

The patient may notice:

  • Increasing abdominal size

  • Tight abdomen

  • Weight gain

  • Swollen legs

  • Breathlessness

  • Reduced appetite

In a cirrhosis patient, new or worsening ascites should never be treated casually.

Treatment can include:

  • Sodium restriction

  • Diuretics

  • Therapeutic paracentesis

  • Albumin in appropriate situations

  • Treatment of infection if present

  • TIPS in selected refractory cases

  • Liver transplant evaluation in advanced disease

9. Hepatic Encephalopathy

When a severely diseased liver cannot adequately process certain substances, toxins can contribute to altered brain function.

Symptoms may include:

  • Excessive sleepiness

  • Altered sleep cycle

  • Confusion

  • Behaviour change

  • Poor concentration

  • Disorientation

  • Hand-flapping tremor

  • Coma in severe cases

This condition requires proper evaluation because triggers such as:

  • Infection

  • Constipation

  • GI bleeding

  • Dehydration

  • Electrolyte abnormalities

  • Kidney dysfunction

may precipitate an episode.

Treatment commonly includes medicines to reduce intestinal toxin production, alongside correction of the precipitating cause.

10. Liver Cancer — Hepatocellular Carcinoma

The most common primary liver cancer is:

HCC — Hepatocellular Carcinoma.

The risk is increased particularly in patients with:

  • Cirrhosis

  • Chronic hepatitis B

  • Chronic hepatitis C

  • Certain advanced chronic liver diseases

Patients at sufficiently increased risk require surveillance rather than waiting for symptoms.

Current AASLD guidance recommends HCC surveillance every six months with abdominal ultrasound plus AFP for patients with cirrhosis and selected chronic hepatitis B populations.

How Is Modern Liver Disease Investigated?

Modern liver evaluation is no longer based on a single SGPT/ALT value.

A more complete assessment may include several layers.

1. Liver Function Tests

Common tests include:

  • Bilirubin

  • AST / SGOT

  • ALT / SGPT

  • Alkaline phosphatase

  • GGT

  • Albumin

  • Total protein

But remember:

Normal liver enzymes do not always mean a completely healthy liver.

A patient can have significant fibrosis or cirrhosis despite relatively modest liver-enzyme abnormalities.

2. CBC and Platelet Count

Platelet count is particularly important.

A falling platelet count may occasionally provide an early clue to:

  • Splenomegaly

  • Portal hypertension

  • Advanced liver fibrosis

although several other diseases can also lower platelets.

3. Ultrasound

Ultrasound may assess:

  • Fatty liver

  • Liver size

  • Liver surface

  • Portal vein

  • Spleen size

  • Ascites

  • Gallbladder

  • Suspicious liver lesions

But ultrasound alone cannot always accurately stage liver fibrosis.

4. FIB-4

FIB-4 is a simple non-invasive fibrosis risk calculation using:

  • Age

  • AST

  • ALT

  • Platelet count

It can help determine whether further fibrosis evaluation is required.

AASLD describes FIB-4 as a useful initial non-invasive assessment, commonly followed by elastography in patients whose result suggests increased risk.

5. FibroScan / Liver Elastography

FibroScan is a form of vibration-controlled transient elastography—VCTE.

It estimates:

Liver stiffness

which can help assess the probability of fibrosis.

It can also help quantify liver fat using associated measurements.

Modern liver practice increasingly uses non-invasive tests such as FIB-4, VCTE/FibroScan and MR elastography, reducing the need for liver biopsy in many situations.

But a FibroScan result should never be interpreted in isolation.

Inflammation, congestion, food intake and other factors can influence liver-stiffness measurements.

6. CT and MRI

Contrast-enhanced CT or MRI becomes important when evaluating:

  • Liver masses

  • Suspected liver cancer

  • Vascular anatomy

  • Advanced cirrhosis

  • Portal hypertension

  • Certain biliary diseases

A suspicious liver lesion in a cirrhotic patient requires appropriate multiphase imaging rather than relying on ultrasound alone.

7. Upper GI Endoscopy

Endoscopy plays an important role in selected patients with cirrhosis and portal hypertension.

It can identify:

  • Esophageal varices

  • Gastric varices

  • Portal hypertensive changes

  • Other causes of upper-GI bleeding

Not every cirrhosis patient automatically needs repeated endoscopy at identical intervals. Modern risk stratification increasingly incorporates platelet count and non-invasive liver stiffness measurements.

8. Liver Biopsy

Liver biopsy remains useful in selected situations.

However, modern non-invasive assessment means that not every fatty-liver or fibrosis patient requires a biopsy.

Biopsy may still be useful when:

  • Diagnosis remains unclear

  • Different liver diseases need distinction

  • Histological information will change treatment

  • Non-invasive tests give conflicting information

What Are the Most Advanced Treatments Available for Liver Disease Today?

There is no single “best liver treatment.”

The most advanced treatment is the one directed at the actual cause and stage of disease.

Advanced Treatment 1: Modern Treatment of Fatty Liver / MASH

The foundation remains:

Weight reduction

Regular physical activity

Diabetes control

Blood-pressure control

Cholesterol and triglyceride management

Treatment of obesity

But this field has changed considerably.

Resmetirom

In March 2024, the US FDA approved resmetirom for adults with non-cirrhotic MASH/NASH and moderate-to-advanced fibrosis, alongside diet and exercise.

Semaglutide

The US FDA has subsequently approved semaglutide for MASH in adults with moderate-to-advanced fibrosis, and AASLD updated its guidance on semaglutide therapy in 2025.

Important for Indian patients

Regulatory approval, availability, exact indication and reimbursement vary by country.

These medicines should therefore not be started simply because someone has an ultrasound showing “Grade 1 fatty liver.”

The patient first needs proper metabolic and fibrosis assessment.

Advanced Treatment 2: Modern Hepatitis C Cure

Current oral direct-acting antivirals have transformed hepatitis C from a difficult chronic infection into one that is curable in more than 95% of appropriately treated patients.

This is one reason anyone found to be anti-HCV positive should undergo proper confirmatory evaluation rather than ignoring the result for years.

Advanced Treatment 3: Hepatitis B Viral Suppression

Modern antiviral medicines can strongly suppress hepatitis B viral replication.

WHO recommends high-resistance-barrier medicines such as:

Tenofovir

or

Entecavir

when antiviral treatment is indicated.

Patients require individualized decisions based on factors including:

  • HBV DNA

  • ALT

  • Fibrosis

  • Cirrhosis

  • Age

  • Family history

  • Coinfections

  • Other risk factors

Treatment can greatly reduce disease progression, but chronic hepatitis B generally requires ongoing monitoring even when viral load becomes suppressed.

Advanced Treatment 4: Endoscopic Variceal Therapy

Patients with portal hypertension can develop enlarged veins in the food pipe called:

Esophageal Varices.

If these bleed, the situation can become life-threatening.

Modern treatment may include:

  • Resuscitation

  • Appropriate vasoactive medicines

  • Antibiotics

  • Urgent endoscopy

  • Endoscopic variceal band ligation

For selected high-risk bleeding patients, early TIPS may be considered.

Advanced Treatment 5: TIPS

TIPS stands for:

Transjugular Intrahepatic Portosystemic Shunt

It is an advanced interventional-radiology procedure.

A channel is created inside the liver connecting part of the portal venous system to the systemic venous circulation.

The purpose is to reduce severe portal hypertension.

TIPS can be considered in selected patients with:

  • Recurrent or difficult variceal bleeding

  • Refractory ascites

  • Certain other complications of portal hypertension

However:

TIPS is not suitable for every cirrhosis patient.

Risks include worsening hepatic encephalopathy and problems in patients with poor liver or cardiac reserve.

Careful patient selection is therefore critical.

Advanced Treatment 6: Large-Volume Paracentesis + Albumin

Patients with severe tense ascites may require drainage through:

Therapeutic paracentesis.

When large volumes of fluid are removed, albumin may be administered according to clinical guidelines to reduce circulatory complications.

This can provide major symptomatic relief, although recurrent ascites indicates significant portal hypertension and should lead to reassessment of overall liver status.

Advanced Treatment 7: Modern Treatment of Liver Cancer

Treatment of hepatocellular carcinoma has advanced dramatically.

The correct treatment depends upon:

  • Number of tumors

  • Tumor size

  • Location

  • Presence of vascular invasion

  • Spread outside the liver

  • Liver function

  • Portal hypertension

  • Overall condition

Options may include:

Surgical Resection

Removal of part of the liver can potentially cure selected early liver cancers in patients with adequate remaining liver function.

Radiofrequency Ablation — RFA

Heat energy is used to destroy selected small tumors.

Microwave Ablation — MWA

Another thermal-ablation technique increasingly used for selected liver tumors.

AASLD recognises thermal ablation, including RFA and MWA, as potentially curative treatment for appropriately selected small HCCs.

TACE

Transarterial Chemoembolization

Chemotherapy and embolic material are delivered directly through the tumor's arterial blood supply in selected patients.

TARE / Radioembolization

Radioactive microspheres can be delivered through the hepatic arterial circulation in selected liver tumors.

Systemic Therapy and Immunotherapy

Modern systemic treatment for advanced HCC increasingly includes targeted medicines and immune-checkpoint inhibitor-based combinations.

The exact regimen depends on tumor stage, liver function, bleeding risk and multiple patient-specific factors.

Liver Transplantation

For carefully selected patients with both cirrhosis and HCC, transplantation can treat:

The cancer

and

The underlying diseased liver

simultaneously.

Advanced Treatment 8: Liver Transplantation

Liver transplantation represents definitive treatment for selected patients with end-stage liver failure and certain appropriately selected liver cancers.

A transplant may be considered when other treatments can no longer adequately compensate for irreversible liver failure.

Potential indications can include:

  • Advanced decompensated cirrhosis

  • Recurrent difficult ascites

  • Repeated variceal bleeding

  • Progressive liver failure

  • Selected acute liver failure

  • Selected liver cancers

  • Certain metabolic diseases

Patients should ideally be referred for transplant assessment before they become critically ill, when appropriate.

Evaluation and transplantation take place through dedicated liver-transplant programmes.

Can Cirrhosis Be Reversed?

This question requires careful wording.

Established advanced cirrhosis should not be advertised as something that can simply be “cured” with medicine.

However, removing or controlling the underlying cause can sometimes produce meaningful improvement in liver function and, in some conditions, regression of fibrosis.

Examples include:

  • Curing hepatitis C

  • Suppressing hepatitis B

  • Complete alcohol abstinence

  • Major metabolic improvement in MASH

  • Treating autoimmune liver disease appropriately

But once significant decompensation has occurred, patients may still require management of complications and evaluation for transplantation.

Does Every Fatty Liver Become Cirrhosis?

No.

Many people with simple steatosis never develop advanced liver disease.

The challenge is identifying the subgroup developing:

Inflammation + progressive fibrosis.

That is why modern fatty-liver assessment increasingly focuses on fibrosis risk, rather than simply reporting “Grade I, II or III fatty liver” on ultrasound.

What Does a FibroScan Score of 15 kPa Mean?

A liver-stiffness value around this range can suggest significant or advanced fibrosis in certain clinical settings, but:

There is no universal interpretation of one FibroScan number for every liver disease.

Cut-offs differ according to:

  • Underlying disease

  • Clinical context

  • Inflammation

  • Congestion

  • Fasting status

  • Technique used

Current AASLD guidance increasingly combines liver stiffness with other information such as platelet count when assessing fibrosis and portal hypertension.

Therefore:

Don't diagnose cirrhosis from one number seen on the report without proper interpretation.

What Symptoms Suggest Advanced Liver Disease?

Seek medical evaluation for:

  • Jaundice

  • Abdominal swelling

  • Leg swelling

  • Vomiting blood

  • Black stools

  • Confusion

  • Excessive sleepiness

  • Unexplained weight loss

  • Significant muscle loss

  • Persistent itching

  • Recurrent fever

  • Reduced urine output

  • Increasing weakness

Vomiting blood, black stools, severe confusion or rapidly worsening jaundice can represent an emergency.

Who Should Consider a Liver Checkup?

A liver assessment is particularly useful for people with:

  • Diabetes

  • Obesity

  • Metabolic syndrome

  • High triglycerides

  • Significant alcohol intake

  • Known fatty liver

  • HBsAg positivity

  • Anti-HCV positivity

  • Persistently abnormal liver enzymes

  • Family history of chronic liver disease

  • Previous jaundice

  • Enlarged liver or spleen

  • Low platelets without a clear explanation

  • Long-term medicines potentially affecting the liver

What Can a Comprehensive Liver Evaluation Include?

Depending upon the patient, a structured evaluation may include:

Clinical history and examination

CBC and platelet count

Liver-function tests

Kidney-function tests

PT/INR

Blood sugar and HbA1c

Lipid profile

Hepatitis B and C testing

Ultrasound abdomen

FIB-4 calculation

FibroScan/elastography when indicated

AFP and HCC surveillance in appropriate high-risk patients

Upper-GI endoscopy when required

Contrast CT/MRI in selected patients

Etiology-specific tests for autoimmune, metabolic or inherited disease when appropriate

The objective is not to order every test for every patient.

The objective is:

Identify the cause + determine fibrosis stage + detect complications + treat before irreversible decompensation occurs.

Liver Cancer Surveillance: Don't Wait for Symptoms

Patients with cirrhosis and selected patients with chronic hepatitis B should not simply wait until they develop pain or weight loss.

Current AASLD guidance recommends six-monthly liver cancer surveillance with ultrasound and AFP for appropriate high-risk populations.

When a suspicious abnormality is discovered, contrast-enhanced multiphase CT or MRI may then be required.

Early detection can radically change the range of available treatment options.

Myths About Liver Treatment

“My SGPT is normal, so my liver is perfect.”

Not necessarily.

Significant fibrosis can occasionally be present despite relatively unremarkable enzymes.

“Fatty liver only needs a liver tonic.”

No.

Metabolic fatty liver treatment focuses largely on weight, diabetes, metabolic risk and fibrosis assessment.

“Once hepatitis C occurs, it remains forever.”

No.

Modern DAAs can cure more than 95% of appropriately treated hepatitis C infections.

“Hepatitis B positive means immediate liver failure.”

No.

Hepatitis B has multiple phases. Many patients can remain clinically well for years, but appropriate monitoring and antiviral treatment when indicated are important.

“Ascites means just remove the water.”

No.

Drainage treats the fluid—not necessarily the underlying portal hypertension and liver disease.

“Every cirrhosis patient needs a transplant immediately.”

No.

Many patients can remain compensated and stable with appropriate treatment and monitoring.

Transplantation is considered when the severity, complications and prognosis justify it.

Liver Disease Treatment in Agra & Nearby Regions

Patients searching for:

Liver specialist in Agra
Liver doctor in Agra
Fatty liver treatment Agra
Cirrhosis treatment Agra
FibroScan doctor Agra
Hepatitis B treatment Agra
Hepatitis C treatment Agra
Ascites treatment Agra
Portal hypertension treatment Agra
Liver cancer evaluation Agra
Hepatologist near me
Advanced liver treatment Agra

should focus first on accurate diagnosis and fibrosis staging.

Patients may seek evaluation from Agra, Civil Lines, Church Road, Khandari, Dayal Bagh, Kamla Nagar, Sikandra, Bodla, Shahganj, Lohamandi, Tajganj, Trans Yamuna, Runakta, Achhnera, Kiraoli, Etmadpur, Fatehabad, Shamshabad and Fatehpur Sikri, as well as the surrounding referral region including Mathura, Vrindavan, Govardhan, Farah, Raya, Baldeo, Firozabad, Tundla, Shikohabad, Hathras, Etah, Mainpuri, Bharatpur and Dholpur.

Advanced procedures such as TIPS, complex liver-cancer interventions and liver transplantation require appropriately equipped specialist centres, and referral should be arranged when the patient's condition warrants them.

Frequently Asked Questions About Liver Disease

Is fatty liver reversible?

Liver fat and early metabolic liver abnormalities can improve substantially with weight loss, exercise and metabolic control. The degree to which established fibrosis reverses varies according to stage and cause.

Is there medicine for fatty liver now?

Yes, the field is evolving. Resmetirom and semaglutide have received US FDA approval for specific groups of adults with MASH and moderate-to-advanced fibrosis. They are not treatments for every person whose ultrasound simply reports fatty liver, and country-specific approval and availability must be considered.

Can hepatitis C be completely cured?

Yes. Modern oral direct-acting antivirals cure more than 95% of appropriately treated patients.

Can hepatitis B be cured?

Current oral antiviral treatment is usually aimed at sustained viral suppression rather than guaranteeing complete eradication. Tenofovir and entecavir are internationally recommended first-line options when treatment is indicated.

What is FibroScan?

FibroScan/VCTE is a non-invasive method of measuring liver stiffness and helping estimate fibrosis risk. It is interpreted alongside clinical findings, blood tests and other imaging.

Does cirrhosis mean cancer?

No.

Cirrhosis and liver cancer are different conditions, although cirrhosis increases the risk of HCC. This is why regular surveillance is important.

What is TIPS?

TIPS is an interventional-radiology procedure that creates a low-resistance pathway between the portal and systemic venous circulation to reduce portal pressure. It is used for selected complications such as refractory ascites or difficult variceal bleeding.

Can someone live normally with compensated cirrhosis?

Some patients remain clinically stable for years when the underlying cause is controlled and complications are appropriately monitored. Regular follow-up remains essential because cirrhosis can progress.

Message From Dr. Karan R. Rawat

Liver disease should not be managed merely by repeatedly checking SGPT and taking a “liver tonic.”

Modern liver care asks four important questions:

1. What caused the liver disease?

2. How much fibrosis or cirrhosis is present?

3. Has portal hypertension or another complication developed?

4. Which treatment can prevent further progression?

Today we can:

Assess fibrosis without biopsy in many patients.

Cure most hepatitis C infections.

Effectively suppress hepatitis B in appropriate patients.

Use targeted treatment for selected patients with MASH.

Control variceal bleeding endoscopically.

Treat refractory portal hypertension with procedures such as TIPS in selected patients.

Treat selected liver cancers using surgery, ablation, embolization, systemic therapy or transplantation.

And when irreversible liver failure develops, liver transplantation can be life-saving in appropriately selected patients.

The most important principle is:

Detect liver disease early—before the first episode of jaundice, ascites, bleeding or confusion.

About the Author — E-E-A-T Medical Profile

Dr. Karan R. Rawat

MBBS, MS, FIAGES, FMAS, DMAS, FICRS, FALS, FISCP, FAIAS, MCLS, FCLS

Dr. Karan R. Rawat is a gastroenterologist, liver doctor, pancreas doctor, intestine surgeon, stomach doctor, gastro surgeon, surgical gastroenterologist, podiatrist, piles doctor, fissure doctor, fistula surgeon, pilonidal surgeon, laser surgeon, laparoscopic surgeon, hernia surgeon, gallbladder surgeon, general surgeon and proctologist practicing in Agra.

His clinical practice includes the assessment and management of fatty liver, abnormal liver-function tests, hepatitis, liver fibrosis, cirrhosis, ascites, portal hypertension and gastrointestinal conditions, along with evaluation and appropriate referral for advanced liver interventions when required.

Consultation

Safe Gastro & Surgery Center (Agra Heart Center)
Church Road, Civil Lines, Agra

Kamla Rawat Hospital / Polyclinic
Runakta, Agra

Appointments: 7398888889

Liver Specialist in Agra | Fatty Liver, Cirrhosis & Advanced Liver Treatment | Dr Karan R Rawat

Looking for advanced liver treatment in Agra? Learn about fatty liver/MASLD, hepatitis B & C, FibroScan, cirrhosis, ascites, portal hypertension, TIPS, liver cancer treatment and liver transplantation from Dr Karan R Rawat, liver and gastrointestinal doctor in Agra.

/liver-disease-advanced-treatment-agra

liver specialist Agra, liver doctor Agra, hepatologist Agra, advanced liver treatment Agra, fatty liver treatment Agra, cirrhosis treatment Agra, FibroScan Agra, liver fibrosis treatment Agra, hepatitis B treatment Agra, hepatitis C treatment Agra, ascites treatment Agra, portal hypertension treatment Agra, liver cancer treatment Agra, gastroenterologist Agra, liver specialist near me

fatty liver doctor Agra, MASLD treatment Agra, MASH treatment Agra, high SGPT treatment Agra, liver swelling treatment Agra, jaundice doctor Agra, enlarged liver Agra, splenomegaly liver disease Agra, TIPS procedure liver, liver transplant evaluation, hepatic encephalopathy treatment, variceal bleeding treatment, endoscopy for cirrhosis, FibroScan liver test

Agra • Civil Lines • Church Road • Khandari • Dayal Bagh • Kamla Nagar • Sikandra • Bodla • Shahganj • Lohamandi • Tajganj • Trans Yamuna • Runakta • Achhnera • Kiraoli • Etmadpur • Fatehabad • Shamshabad • Fatehpur Sikri • Mathura • Vrindavan • Govardhan • Farah • Raya • Baldeo • Firozabad • Tundla • Shikohabad • Hathras • Etah • Mainpuri • Bharatpur • Dholpur

Medical Disclaimer: This article is for patient education and general awareness. Liver diseases vary widely in cause and severity. Medicines, FibroScan, endoscopy, CT/MRI, TIPS, liver-cancer therapy and transplantation should be considered only after individual clinical assessment. Regulatory approval and availability of newer medicines may vary by country.